| Bioactivity | KKI-5 (TFA) is a specific inhibitor of tissue kallikrein. KKI-5 (TFA) can attenuate breast cancer cell invasion[1]. | ||||||
| Invitro | The KKI-5 Peptide corresponds to aa386-391 of bovine kininogen-1 that encompasses the aa388-389 kallikrein proteolytic site. The synthetic KKI-5 can attenuate breast cancer cell invasion, therefore it is investigated for its role in invasion and metastasis of cancer cells[1]. | ||||||
| Name | KKI-5 TFA | ||||||
| Sequence | Ac-Pro-Phe-Arg-Ser-Val-Gln-NH2 | ||||||
| Shortening | Ac-PFRSVQ-NH2 | ||||||
| Formula | C37H56F3N11O11 | ||||||
| Molar Mass | 887.90 | ||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||
| Storage | Sealed storage, away from moisture
*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |